Patents Assigned to Ambit Bioscience Corporation
  • Method of using imidazolothiazole compounds for the treatment of disease
    Patent number: 8129374
    Abstract: Compounds, compositions and methods are provided for modulating the activity of receptor kinases and for the treatment, prevention, or amelioration of one or more symptoms of disease or disorder mediated by receptor kinases.
    Type: Grant
    Filed: August 4, 2010
    Date of Patent: March 6, 2012
    Assignee: Ambit Bioscience Corporation
    Inventors: Shripad Bhagwat, Qi Chao, Robert M. Grotzfeld, Hitesh K. Patel, Kelly G. Sprankle